Oral bisphosphonate compliance and persistence: a matter of choice?
Compliance to oral bisphosphonates is suboptimal, with negative consequences of increased healthcare utilization and less effective fracture risk reduction. Extending dose interval increased adherence only moderately. We used literature derived from multiple chronic conditions to examine the problem of noncompliance with osteoporosis medication. We reviewed the literature on adherence to osteoporosis medication as well as that across multiple chronic conditions to understand what is known about the cause of the poor adherence. Poor compliance to oral medications is due mostly, not to forgetfulness, but to deliberate choice. Gender differences and style of healthcare management also play a role. Preliminary data suggest psychobehavioral interventions may help to improve motivation. We need to understand better reasons for poor compliance before effective interventions can be developed. Forgetfulness is only a small part of poor compliance. Patient preferences must be considered in medication decision making.
- Oral bisphosphonate compliance and persistence: a matter of choice?
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Volume 22, Issue 1 , pp 21-26
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Medication adherence
- Industry Sectors
- Author Affiliations
- 1. Cedars-Sinai/UCLA/OMC, 8641 Wilshire Blvd., Suite 301, Beverly Hills, CA, 90211, USA
- 2. Department of Rheumatology, Park Nicollet Medical Center, St. Louis Park, MN, USA
- 3. Psychiatry and Behavioral Sciences, Sociology, and Psychology and Neuroscience, Duke University Medical School, Durham, NC, USA